NCT00892749View on ClinicalTrials.gov

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Chronic Kidney DiseaseRenal DialysisRenal InsufficiencyHyperphosphatemia
Interventions
DRUG

ASP1585

oral

Trial Locations (4)

Unknown

Chugoku

Chūbu

Kansai

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00892749 - Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis | Biotech Hunter | Biotech Hunter